3086 related articles for article (PubMed ID: 33554490)
21. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
[TBL] [Abstract][Full Text] [Related]
22. The Impact of COVID-19 Pandemic on Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes: A Single-Centre Study in Central Pennsylvania.
Bogale KT; Urban V; Schaefer E; Bangalore Krishna K
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00235. PubMed ID: 34268453
[TBL] [Abstract][Full Text] [Related]
23. Using population data to understand the epidemiology and risk factors for diabetic ketoacidosis in Australian children with type 1 diabetes.
Ampt A; van Gemert T; Craig ME; Donaghue KC; Lain SB; Nassar N
Pediatr Diabetes; 2019 Nov; 20(7):901-908. PubMed ID: 31291024
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Type 1 Diabetes Mellitus and Characteristics of Diabetic Ketoacidosis in Children and Adolescents during the First Two Years of the COVID-19 Pandemic in Vojvodina.
Vorgučin I; Savin M; Stanković Đ; Miljković D; Ilić T; Simić D; Vrebalov M; Milanović B; Barišić N; Stojanović V; Vijatov-Đurić G; Koprivšek K; Vilotijević-Dautović G; Antić J
Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 36013479
[TBL] [Abstract][Full Text] [Related]
25. Trends in Type 1 Diabetic Ketoacidosis During COVID-19 Surges at 7 US Centers: Highest Burden on non-Hispanic Black Patients.
Lavik AR; Ebekozien O; Noor N; Alonso GT; Polsky S; Blackman SM; Chen J; Corathers SD; Demeterco-Berggren C; Gallagher MP; Greenfield M; Garrity A; Rompicherla S; Rapaport R; Yayah Jones NH
J Clin Endocrinol Metab; 2022 Jun; 107(7):1948-1955. PubMed ID: 35380700
[TBL] [Abstract][Full Text] [Related]
26. Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.
Elgenidy A; Awad AK; Saad K; Atef M; El-Leithy HH; Obiedallah AA; Hammad EM; Ahmad FA; Ali AM; Dailah HG; Elhoufey A; Taha SF
Pediatr Res; 2023 Apr; 93(5):1149-1160. PubMed ID: 35953513
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Diabetic Ketoacidosis Among Pediatrics With Type 1 Diabetes Prior to and During COVID-19 Pandemic: A Meta-Analysis of Observational Studies.
Alfayez OM; Aldmasi KS; Alruwais NH; Bin Awad NM; Al Yami MS; Almohammed OA; Almutairi AR
Front Endocrinol (Lausanne); 2022; 13():856958. PubMed ID: 35355556
[TBL] [Abstract][Full Text] [Related]
28. Factors Associated With Diabetic Ketoacidosis at Onset of Type 1 Diabetes Among Pediatric Patients: A Systematic Review.
Rugg-Gunn CEM; Dixon E; Jorgensen AL; Usher-Smith JA; Marcovecchio ML; Deakin M; Hawcutt DB
JAMA Pediatr; 2022 Dec; 176(12):1248-1259. PubMed ID: 36215053
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes: A report from a tertiary medical center in Central Pennsylvania.
Bogale KT; Hale DE; Schaefer E; Bangalore Krishna K
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00186. PubMed ID: 33855199
[TBL] [Abstract][Full Text] [Related]
30. Ketoacidosis at diagnosis of type 1 diabetes in French children and adolescents.
Choleau C; Maitre J; Filipovic Pierucci A; Elie C; Barat P; Bertrand AM; de Kerdanet M; Letallec C; Levy-Marchal C; Nicolino M; Tubiana-Rufi N; Cahané M; Robert JJ;
Diabetes Metab; 2014 Apr; 40(2):137-42. PubMed ID: 24332018
[TBL] [Abstract][Full Text] [Related]
31. Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data.
Dell'Aquila K; Lee J; Wang SH; Alamuri TT; Jennings R; Tang H; Mahesh S; Leong TJ; Fleysher R; Henninger EM; Veeraraghavan S; Mirhaji P; Hou W; Herold KC; Duong TQ
Diabetes Obes Metab; 2023 Sep; 25(9):2482-2494. PubMed ID: 37254311
[TBL] [Abstract][Full Text] [Related]
32. Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children?
Rabbone I; Schiaffini R; Cherubini V; Maffeis C; Scaramuzza A;
Diabetes Care; 2020 Nov; 43(11):2870-2872. PubMed ID: 32778554
[TBL] [Abstract][Full Text] [Related]
33. The Silent Epidemic of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents in Italy During the COVID-19 Pandemic in 2020.
Cherubini V; Marino M; Scaramuzza AE; Tiberi V; Bobbio A; Delvecchio M; Piccinno E; Ortolani F; Innaurato S; Felappi B; Gallo F; Ripoli C; Ricciardi MR; Pascarella F; Stamati FA; Citriniti F; Arnaldi C; Monti S; Graziani V; De Berardinis F; Giannini C; Chiarelli F; Zampolli M; De Marco R; Bracciolini GP; Grosso C; De Donno V; Piccini B; Toni S; Coccioli S; Cardinale G; Bassi M; Minuto N; D'Annunzio G; Maffeis C; Marigliano M; Zanfardino A; Iafusco D; Rollato AS; Piscopo A; Curto S; Lombardo F; Bombaci B; Sordelli S; Mameli C; Macedoni M; Rigamonti A; Bonfanti R; Frontino G; Predieri B; Bruzzi P; Mozzillo E; Rosanio F; Franzese A; Piredda G; Cardella F; Iovane B; Calcaterra V; Berioli MG; Lasagni A; Pampanini V; Patera PI; Schiaffini R; Rutigliano I; Meloni G; De Sanctis L; Tinti D; Trada M; Guerraggio LP; Franceschi R; Cauvin V; Tornese G; Franco F; Musolino G; Maltoni G; Talarico V; Iannilli A; Lenzi L; Matteoli MC; Pozzi E; Moretti C; Zucchini S; Rabbone I; Gesuita R
Front Endocrinol (Lausanne); 2022; 13():878634. PubMed ID: 35784550
[TBL] [Abstract][Full Text] [Related]
34. A Long-Term Comparison of Presenting Characteristics of Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic.
Kaya G; Cimbek EA; Yeşilbaş O; Bostan YE; Karagüzel G
J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):267-274. PubMed ID: 35308015
[TBL] [Abstract][Full Text] [Related]
35. Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature.
Gorchane A; Ach T; Sahli J; Abdelkrim AB; Mallouli M; Bellazreg F; Hachfi W; Chaieb MC; Ach K
Front Endocrinol (Lausanne); 2023; 14():1234256. PubMed ID: 37564978
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?
Zubkiewicz-Kucharska A; Seifert M; Stępkowski M; Noczyńska A
Adv Clin Exp Med; 2021 Feb; 30(2):127-134. PubMed ID: 33599404
[TBL] [Abstract][Full Text] [Related]
37. Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: an international retrospective observational study.
Ponmani C; Nijman RG; Roland D; Barrett M; Hulse T; Whittle V; Lyttle MD;
Arch Dis Child; 2023 Oct; 108(10):799-807. PubMed ID: 37197894
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology and clinical course of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus].
Pietrzak I; Mianowska B; Zmysłowska A; Fendler W; Młynarski W; Szadkowska A
Pediatr Endocrinol Diabetes Metab; 2013; 19(4):137-42. PubMed ID: 25612813
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Initial Presentation of Pediatric Diabetes Before and During the Coronavirus Disease 2019 Pandemic Era.
Lee Y; Kim M; Oh K; Kang E; Rhie YJ; Lee J; Hong YH; Shin YL; Kim JH
J Korean Med Sci; 2022 Jun; 37(22):e176. PubMed ID: 35668686
[TBL] [Abstract][Full Text] [Related]
40. Presentations, Complications, and Challenges Encountered During Management of Type 1 Diabetes in Egyptian Children During COVID-19 Pandemic: A Single-Center Experience.
Abdou M; Hassan MM; Hassanein SA; Elsebaie EH; Shamma RA
Front Endocrinol (Lausanne); 2022; 13():814991. PubMed ID: 35360079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
